These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24053715)

  • 21. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
    Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
    Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield.
    Lavery HJ; Martinez-Suarez HJ; Abaza R
    BJU Int; 2011 Jun; 107(11):1802-5. PubMed ID: 21070571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes.
    Wang YC; Wu J; Dai B; Shen YJ; Ma CG; Ye DW; Zhu YP
    World J Surg Oncol; 2019 Dec; 17(1):225. PubMed ID: 31864368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?
    Holmer M; Bendahl PO; Davidsson T; Gudjonsson S; Månsson W; Liedberg F
    World J Urol; 2009 Aug; 27(4):521-6. PubMed ID: 19145436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended pelvic lymph node dissection in muscle invasive bladder cancer.
    Katims AB; Bochner BH
    Curr Opin Urol; 2023 Jul; 33(4):252-257. PubMed ID: 37021936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
    Lestingi JFP; Guglielmetti GB; Trinh QD; Coelho RF; Pontes J; Bastos DA; Cordeiro MD; Sarkis AS; Faraj SF; Mitre AI; Srougi M; Nahas WC
    Eur Urol; 2021 May; 79(5):595-604. PubMed ID: 33293077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Pathology Findings in Patients Who Have Undergone Radical Cystectomy/Cystoprostatectomy With Extended Versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder: A Contemporary Analysis.
    Kagan J; Alemozaffar M; Carthon B; Osunkoya AO
    Int J Surg Pathol; 2021 Apr; 29(2):150-154. PubMed ID: 32573301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Safety of Extended Lymph Node Dissection during Radical Surgery in Patients with Bladder Cancer: A Meta-Analysis.
    Hu H
    Arch Esp Urol; 2024 Apr; 77(3):303-314. PubMed ID: 38715172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis.
    Mandel P; Tilki D; Eslick GD
    Urol Oncol; 2014 Nov; 32(8):1184-90. PubMed ID: 25027683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
    Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
    Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
    Fang AC; Ahmad AE; Whitson JM; Ferrell LD; Carroll PR; Konety BR
    Cancer; 2010 Apr; 116(8):1901-8. PubMed ID: 20186823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.
    Bochner BH; Herr HW; Reuter VE
    J Urol; 2001 Dec; 166(6):2295-6. PubMed ID: 11696756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.
    Karl A; Carroll PR; Gschwend JE; Knüchel R; Montorsi F; Stief CG; Studer UE
    Eur Urol; 2009 Apr; 55(4):826-35. PubMed ID: 19150582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP
    Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.